Koyfin Home > Directory > Health Care > Adamas Pharma > Price / Book

Adamas Pharma Price / Book Chart (ADMS)

Adamas Pharma annual/quarterly Price / Book from 2014 to 2020. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Adamas Pharma Price / Book for the quarter ending March 03, 2020 was 5.61 a -9.80% decrease of -0.55 year over year
  • Adamas Pharma Price / Book for the last 12 months ending March 03, 2020 was 5.61 a -9.80% decrease of -0.55 year over year
  • Adamas Pharma Annual Price / Book for 2020 was 5.61 a -7.41% decrease of -0.42 from 2019
  • Adamas Pharma Annual Price / Book for 2020 was 6.03 a -6.67% decrease of -0.40 from 2019
  • Adamas Pharma Annual Price / Book for 2020 was 6.43 a 4.17% increase of 0.27 from 2019
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS Price / Book Data

03/20205.61
03/20206.03
02/20206.43
02/20206.16
02/20206.24
02/20206.73
02/20207.40
02/20208.16
02/20208.02
02/20207.88

Annual ADMS Price / Book Data

20205.61
20206.03
20206.43
20206.16
20206.24
20206.73
20207.40
20208.16
20208.02
20207.88